Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Advances in Enzyme Regulation

Volumn 22, Issue C, 1984, Pages 27-55

  Chou, Ting Chao ^a   Talalay, Paul ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; 1,10-PHENANTHROLINE; ADENOSINE DIPHOSPHATE; ADENOSINE DIPHOSPHATE RIBOSE; ALCOHOL DEHYDROGENASE; ANTIMETABOLITE; DEOXYURIDINE; DNA; ENZYME INHIBITOR; PHENANTHROLINE DERIVATIVE; PYRETHROID; ROTENONE;

ANIMAL; ARTICLE; CHEMICAL MODEL; DOSE RESPONSE; DRUG INTERACTION; KINETICS; LEUKEMIA L 1210; METABOLISM; MOUSE;

ADENOSINE DIPHOSPHATE; ADENOSINE DIPHOSPHATE RIBOSE; ALCOHOL DEHYDROGENASE; ALCOHOL OXIDOREDUCTASES; ANIMAL; ANTIMETABOLITES; DEOXYURIDINE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; KINETICS; LEUKEMIA L1210; MICE; MODELS, CHEMICAL; PHENANTHROLINES; PYRETHRINS; ROTENONE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0021118703     PISSN: 00652571     EISSN: None     Source Type: Journal    
DOI: 10.1016/0065-2571(84)90007-4     Document Type: Article

References (62)

1. The kinetics of enzyme catalyzed reactions with two or more substrates or products
2. Multiple inhibition analysis
3. Relationships between inhibition constants and fractional inhibition in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types and mechanisms of inhibition
4. Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands
5. On the determination of availability of ligand binding sites in steady-state systems
6. A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems
7. The application of the logistic function to experimental data
8. A new theory of the cancer-inducing mechanism
9. Analysis of combined drug effects: A new look at a very old problem
10. Die Kinetik der Invertinwirkung
11. The combinations of hemoglobin with oxygen and with carbon monoxide
12. The adsorption of gases on plane surfaces of glass, mica and platinum
13. The attractions of proteins for small molecules and ions
14. Metabolism and selective effects of 1-β-d-arabinofuranosylcytosine in L1210 and host tissues in vivo
15. The active site of transketolase: Two arginine residues are essential for activity
16. Correlations between glucose-inhibition and control parameters of α-glucosidase kinetics in Apis mellifica haemolymph
17. Canrenome as a partial agonist at the digitalis receptor site of sodium-potassium-activated adenosine triphosphatase
18. Purification and properties of γ-glutamyl transpeptidase from bovine parotid gland
19. Kinetic study of the inhibition of the honeybee haemolymph α-glucosidase in vitro by BAYe 4609, BAYg 5421 and BAYn 5595
20. Kinetic properties and inhibition of Acinetobacter glutaminase-asparaginase
21. Membrane-active drugs potentiate the killing of tumor cells by d-glucosamine
22. A kinetic analysis of l-tryptophan transport in human red blood cells
23. A general procedure for determination of median-effect doses by a double logarithmic transformation of dose-response relationships
24. Comparison of dose-effect relationships of carcinogens following low-dose chronic exposure and high-dose single injection: An analysis by the median-effect principle
25. Carcinogenic risk assessment by a mass-action law principle: Application to large scale chronic feeding experiment with 2-acetylaminofluorene (2-AAF)
26. Therapy of DMBA-induced rat mammary carcinomas with combinations of 5-fluorouracil and 2α-methyldihydrotestosterone propionate
27. 1 receptor binding in brain tissue
28. Agonist-mediated conformational changes of muscarinic receptors in rat brain
29. Effects of 1-arylpyrroles and naphthoflavones upon cytochrome P-450 dependent monooxygenase activities
30. A model of labelled-ligand displacement assay resulting in logit-log relationships
31. Computer simulation of drug effects: Quantitation of synergism, summation and antagonism of multiple drugs
32. The employment of combinations of drugs in the chemotherapy of neoplasia: A review
33. Synergy, additivism and antagonism in immunosuppression: A critical review
34. Die quantitation probleme der pharmakologie
35. The problem of synergism and antagonism of combined drugs
36. Effect of more than one inhibitor
37. Effect of more than one inhibitor
38. Synergism and potentiation with special reference to the combination of structural analogues
39. Mechanisms of chemotherapeutic synergy
40. The problem of drug efficacy: An exercise in dissection
41. Drug synergism in anti-neoplastic chemotherapy
42. Approaches to the combination chemotherapy of transplantable neoplasms
43. Evaluation of combination chemotherapy with three drugs
44. Combination therapy: Some concepts and results
45. Synergism and antagonism among antitumor agents
46. Approaches to the rational combination of antimetabolites for cancer chemotherapy
47. The nature and control of reactions in bioluminescence
48. Complex formation of apo-enzyme, coenzyme and substrate of d-amino acid oxidase
49. Analysis of the action of drugs and drug combinations
50. Analysis of the action of drugs and drug combinations
51. Studies on liver alcohol dehydrogenase complexes
52. The system of double inhibitions
53. Methods of analysis of double inhibitor experiments
54. The kinetics of pig heart triphosphopyridine nucleotide-isocitrate dehydrogenase
55. Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors
56. Toxicity of rotenone and pyrethrins alone and in combination